# Comparative Effectiveness of COPD Treatments

> **NCT03376295** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 3954 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** LABA and the LAMA tiotropium (LABA-TIO)
- **DRUG:** LABA and an ICS (LABA-ICS)

## Key facts

- **NCT ID:** NCT03376295
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 3954 (ACTUAL)
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03376295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03376295, "Comparative Effectiveness of COPD Treatments". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03376295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*